Proenkephalin-A gene regulation in the rat striatum: Influence of lithium and haloperidol

Subbiah Sivam, C. Strunk, D. R. Smith, J. S. Hong

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

This report explores the influence of lithium and haloperidol on (Met5)-enkephalin (ME) biosynthesis in the rat striatum. Male Fischer 344 rats were treated intraperitoneally with lithium chloride (4 mEq/kg/day) for 2, 4, or 6 days and sacrificed 24 hr after the last dose; in addition, the effect of lithium at 2 and 24 hr after a single dose was studied. Serum levels increased in a time-related manner on repeated administration of lithium. Lithium increased the striatal ME content (native ME) in a time-dependent fashion, reaching 160% of control following six doses; no changes in ME were observed in hypothalamus and hippocampus. ME levels recovered to control values 8 days after cessation on a 4-day course of repeated administration (4 mEq/kg/day) of lithium. In an attempt to characterize the nature of this selective increase of ME content in the striatum, the precursor content (cryptic ME) as well as the preproenkephalin mRNA abundance was determined. Lithium increased the precursor content in a time-dependent fashion and this pattern closely paralleled the increase in native ME content. The preproenkephalin mRNA abundance with respect to control was quantitated by blot-hybridization of total RNA with a 32P-labeled cDNA probe derived from rat brain. Lithium increased the mRNA abundance following repeated doses for 4 or 6 days. Concurrent administration of an opiate antagonist, naltrexone (5 mg/kg/day), for 4 days did not influence the changes induced by lithium. On repeated administration (1 mg/kg/day) for 4 days, the neuroleptic, haloperidol, increased the biosynthesis of ME which was more marked than that of lithium administered for the same period; the combination of a haloperidol and lithium regimen did not lead to an additive or synergistic effect. The results indicate that, like haloperidol, repeated injections of lithium increase the biosynthesis of ME in the basal ganglia by increasing the preproenkephalin mRNA abundance and translation process.

Original languageEnglish (US)
Pages (from-to)186-191
Number of pages6
JournalMolecular Pharmacology
Volume30
Issue number2
StatePublished - 1986
Externally publishedYes

Fingerprint

Haloperidol
Enkephalins
Lithium
Genes
Messenger RNA
Opiate Alkaloids
proenkephalin
Lithium Chloride
Corpus Striatum
Naltrexone
Inbred F344 Rats
Protein Biosynthesis
Basal Ganglia
Antipsychotic Agents
Hypothalamus
Hippocampus
Complementary DNA
RNA
Injections

ASJC Scopus subject areas

  • Pharmacology

Cite this

Proenkephalin-A gene regulation in the rat striatum : Influence of lithium and haloperidol. / Sivam, Subbiah; Strunk, C.; Smith, D. R.; Hong, J. S.

In: Molecular Pharmacology, Vol. 30, No. 2, 1986, p. 186-191.

Research output: Contribution to journalArticle

Sivam, Subbiah ; Strunk, C. ; Smith, D. R. ; Hong, J. S. / Proenkephalin-A gene regulation in the rat striatum : Influence of lithium and haloperidol. In: Molecular Pharmacology. 1986 ; Vol. 30, No. 2. pp. 186-191.
@article{e2c50f9360e841bba0dbca736a1eedb5,
title = "Proenkephalin-A gene regulation in the rat striatum: Influence of lithium and haloperidol",
abstract = "This report explores the influence of lithium and haloperidol on (Met5)-enkephalin (ME) biosynthesis in the rat striatum. Male Fischer 344 rats were treated intraperitoneally with lithium chloride (4 mEq/kg/day) for 2, 4, or 6 days and sacrificed 24 hr after the last dose; in addition, the effect of lithium at 2 and 24 hr after a single dose was studied. Serum levels increased in a time-related manner on repeated administration of lithium. Lithium increased the striatal ME content (native ME) in a time-dependent fashion, reaching 160{\%} of control following six doses; no changes in ME were observed in hypothalamus and hippocampus. ME levels recovered to control values 8 days after cessation on a 4-day course of repeated administration (4 mEq/kg/day) of lithium. In an attempt to characterize the nature of this selective increase of ME content in the striatum, the precursor content (cryptic ME) as well as the preproenkephalin mRNA abundance was determined. Lithium increased the precursor content in a time-dependent fashion and this pattern closely paralleled the increase in native ME content. The preproenkephalin mRNA abundance with respect to control was quantitated by blot-hybridization of total RNA with a 32P-labeled cDNA probe derived from rat brain. Lithium increased the mRNA abundance following repeated doses for 4 or 6 days. Concurrent administration of an opiate antagonist, naltrexone (5 mg/kg/day), for 4 days did not influence the changes induced by lithium. On repeated administration (1 mg/kg/day) for 4 days, the neuroleptic, haloperidol, increased the biosynthesis of ME which was more marked than that of lithium administered for the same period; the combination of a haloperidol and lithium regimen did not lead to an additive or synergistic effect. The results indicate that, like haloperidol, repeated injections of lithium increase the biosynthesis of ME in the basal ganglia by increasing the preproenkephalin mRNA abundance and translation process.",
author = "Subbiah Sivam and C. Strunk and Smith, {D. R.} and Hong, {J. S.}",
year = "1986",
language = "English (US)",
volume = "30",
pages = "186--191",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Proenkephalin-A gene regulation in the rat striatum

T2 - Influence of lithium and haloperidol

AU - Sivam, Subbiah

AU - Strunk, C.

AU - Smith, D. R.

AU - Hong, J. S.

PY - 1986

Y1 - 1986

N2 - This report explores the influence of lithium and haloperidol on (Met5)-enkephalin (ME) biosynthesis in the rat striatum. Male Fischer 344 rats were treated intraperitoneally with lithium chloride (4 mEq/kg/day) for 2, 4, or 6 days and sacrificed 24 hr after the last dose; in addition, the effect of lithium at 2 and 24 hr after a single dose was studied. Serum levels increased in a time-related manner on repeated administration of lithium. Lithium increased the striatal ME content (native ME) in a time-dependent fashion, reaching 160% of control following six doses; no changes in ME were observed in hypothalamus and hippocampus. ME levels recovered to control values 8 days after cessation on a 4-day course of repeated administration (4 mEq/kg/day) of lithium. In an attempt to characterize the nature of this selective increase of ME content in the striatum, the precursor content (cryptic ME) as well as the preproenkephalin mRNA abundance was determined. Lithium increased the precursor content in a time-dependent fashion and this pattern closely paralleled the increase in native ME content. The preproenkephalin mRNA abundance with respect to control was quantitated by blot-hybridization of total RNA with a 32P-labeled cDNA probe derived from rat brain. Lithium increased the mRNA abundance following repeated doses for 4 or 6 days. Concurrent administration of an opiate antagonist, naltrexone (5 mg/kg/day), for 4 days did not influence the changes induced by lithium. On repeated administration (1 mg/kg/day) for 4 days, the neuroleptic, haloperidol, increased the biosynthesis of ME which was more marked than that of lithium administered for the same period; the combination of a haloperidol and lithium regimen did not lead to an additive or synergistic effect. The results indicate that, like haloperidol, repeated injections of lithium increase the biosynthesis of ME in the basal ganglia by increasing the preproenkephalin mRNA abundance and translation process.

AB - This report explores the influence of lithium and haloperidol on (Met5)-enkephalin (ME) biosynthesis in the rat striatum. Male Fischer 344 rats were treated intraperitoneally with lithium chloride (4 mEq/kg/day) for 2, 4, or 6 days and sacrificed 24 hr after the last dose; in addition, the effect of lithium at 2 and 24 hr after a single dose was studied. Serum levels increased in a time-related manner on repeated administration of lithium. Lithium increased the striatal ME content (native ME) in a time-dependent fashion, reaching 160% of control following six doses; no changes in ME were observed in hypothalamus and hippocampus. ME levels recovered to control values 8 days after cessation on a 4-day course of repeated administration (4 mEq/kg/day) of lithium. In an attempt to characterize the nature of this selective increase of ME content in the striatum, the precursor content (cryptic ME) as well as the preproenkephalin mRNA abundance was determined. Lithium increased the precursor content in a time-dependent fashion and this pattern closely paralleled the increase in native ME content. The preproenkephalin mRNA abundance with respect to control was quantitated by blot-hybridization of total RNA with a 32P-labeled cDNA probe derived from rat brain. Lithium increased the mRNA abundance following repeated doses for 4 or 6 days. Concurrent administration of an opiate antagonist, naltrexone (5 mg/kg/day), for 4 days did not influence the changes induced by lithium. On repeated administration (1 mg/kg/day) for 4 days, the neuroleptic, haloperidol, increased the biosynthesis of ME which was more marked than that of lithium administered for the same period; the combination of a haloperidol and lithium regimen did not lead to an additive or synergistic effect. The results indicate that, like haloperidol, repeated injections of lithium increase the biosynthesis of ME in the basal ganglia by increasing the preproenkephalin mRNA abundance and translation process.

UR - http://www.scopus.com/inward/record.url?scp=0022918915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022918915&partnerID=8YFLogxK

M3 - Article

C2 - 3016502

AN - SCOPUS:0022918915

VL - 30

SP - 186

EP - 191

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -